The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics ...

Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene therapies and the blood supply.

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...

Dr. Vinay Prasad, a vocal critic of the agency's moves to greenlight COVID-19 vaccine boosters. Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation ...

Vinay Prasad has worked as a professor of medicine ... He steps into the shoes vacated by Peter Marks, who resigned from the role a few weeks ago – reportedly before being pushed out ...

On first glance, Dr. Vinay Prasad’s medical credentials sound impressive. But look closer and you’ll find a narcissistic attention-seeker peddling misinformation, whose views will cost lives.

The U.S. Food and Drug Administration has tapped Dr. Vinay Prasad, an oncologist who has ... He replaces Dr. Peter Marks, who led the division for 13 years and helped shape Operation Warp Speed ...

NEW ORLEANS — Last year, hundreds of people poured in to hear Peter Marks, the Food and Drug ... the gene therapy field is what stance Vinay Prasad, the fiery hematologist and frequent pharma ...

In late March, Dr. Peter Marks, the Food and Drug Administration ... Seven weeks later, the FDA named Marks’ successor: Dr. Vinay Prasad, a hematologist and oncologist. That wouldn’t ...

where everyone is still talking about Baby KJ and no one wants to talk about Vinay Prasad. Last year, hundreds of people poured in to see Peter Marks, the FDA’s head of biologics, speak at at ASGCT.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist ... He replaces Dr. Peter Marks, who helped lead the division for 13 years and shaped the Operation ...